Nachhaltige Wissenschaft und Forschung

Impulsgebend und zukunftsorientiert

Die ophthalmologische Wissenschaft und Forschung sowie der Transfer in die praktische Anwendung wird von den Augenkliniken in Baden-Württemberg nachhaltig getragen und gefördert. Sie haben Arbeiten von medizinischer Exzellenz hervorgebracht und neueste Behandlungs-instrumente und -methoden auf breiter Ebene zugänglich gemacht.

Die Augenkliniken fördern den Erkenntnisgewinn durch international vernetzte grundlagenwissenschaftliche Arbeiten, Sonderforschungs-bereiche, klinische Forschergruppen und klinische Studien. Vorträge und begutachtete Veröffentlichungen schaffen die Voraussetzungen für eine vorausschauende evidenzbasierte Medizin und sind für alle am Gesundheitsprozess beteiligten Gruppen von unverzichtbarem Wert.
Sie erschließen wegweisende Optionen und erweitern die Möglichkeiten in Früherkennung und Prävention, Diagnostik und Therapie.

Damit die therapeutischen und diagnostischen Methoden im Sinne einer optimalen Patientenversorgung stets dem neuesten Stand der Forschung entsprechen, haben die Augenkliniken ausgewiesene Forschungseinrichtungen angegliedert.

KLINISCHE FORSCHUNGSSCHWERPUNKTE:

  • Artificial Cornea
  • Elektrostimulation
  • Elektrophysiologie
  • Erbliche Netzhauterkrankungen und Sinnesphysiologie
  • Experimentelle Ophthalmochirurgie
  • Experimentelle Vitreoretinale Chirurgie
  • Funktionelle Sehforschung
  • Geschichte der Augenheilkunde
  • Glaskörperersatz
  • Histopathologie des Auges
  • HIV und das Auge
  • Höhen-Ophthalmologie
  • Hornhautkonservierung
  • Hornhauttransplantationstechniken
  • Immunologie von Hornhaut und vorderer Augenkammer
  • Intraokulare Sehhilfen
  • Lasereinsatz an der Hornhaut
  • Molekularbiologie von Aderhautmelanomen
  • Molekulargenetik und Zellbiologie des Auges
  • Neuroprotektion
  • Neuroprotektive Spüllösungen
  • Neurotrophe Faktoren
  • Operative Glaukomtherapie
  • Ophthalmopathologie
  • Refraktive Implantate
  • Retinale Biokompatibilität
  • Retinoblastomforschung
  • Sehbahnforschung
  • Tropenophthalmologie
  • Uveitis

KLINISCHE STUDIEN:

Die nachfolgende Liste gibt einen Überblick über die laufenden und abgeschlossenen klinischen Studien an den Standorten des EyeNet Baden-Württemberg. Diese Liste wird automatisch aus dem Studienregister clinicaltrials.gov extrahiert und erhebt daher keinen Anspruch auf Vollständigkeit.

Freiburg
  • NovaTears® Eye Drops Observational Study NT-003 »Details
  • A Study Demonstrating The Effect Of Latanoprost In Combination With Timolol, Latanoprost Alone And Timolol Alone On Eye Pressure In Open Angle Glaucoma Or Ocular Hypertension In Patients »Details
  • Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension »Details
  • Treatment of Optic Neuritis With Erythropoietin: a Randomised, Double-blind, Placebo-controlled Trial »Details
  • Safety and Efficacy Study of PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) Ophthalmic Solution Compared to GANFORT® Ophthalmic Solution in Open Angle Glaucoma or Ocular Hypertension »Details
  • Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma »Details
  • Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye »Details
  • HELIX, a Double-masked Study of SYL1001 in Patients With Moderate to Severe Dry Eye Disease (DED) »Details
  • Atacicept in Subjects With Optic Neuritis »Details
  • SYL040012, Treatment for Open Angle Glaucoma »Details
  • Post Authorisation Safety Study With Raxone in LHON Patients »Details
  • A Study to Assess Whether PDE5 Inhibitors Increase the Chance of Triggering the Onset of Acute NAION »Details
  • Functional Antigen Matching in Corneal Transplantation »Details
  • Intravitreal Aflibercept Injection in Vision Impairment Due to DME »Details
  • EDoF IOLs vs Monofocal IOL »Details
  • Riboflavin Mediated Corneal Crosslinking for Stabilizing Progression of Keratoconus »Details
  • A Study to Compare the Safety and Efficacy of A New Eye Drop Formulation With OPTIVE™ in Subjects With Dry Eye Disease »Details
  • Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Epidemic Keratoconjunctivitis (EKC) »Details
  • Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO) »Details
  • EAGLE - Multicenter Study of the European Assessment Group for Lysis in the Eye »Details
  • A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis »Details
  • An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMD »Details
  • To Assess the Efficacy and Safety of Intravitreal Ranibizumab in People With Vision Loss Due to Macular Edema »Details
  • Assess the Efficacy/Safety of Intravitreal Ranibizumab in Patients With Vision Loss Due to Choroidal Neovascularization. »Details
  • Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (AMD) »Details
  • Managing Neovascular (Known as "Wet") Age-related Macular Degeneration Over 2 Years Using Different Treatment Schedules of 2 mg Intravitreal Aflibercept Injected in the Eye »Details
  • Efficacy of Ranibizumab Prn Treatment Compared to Aflibercept Bimonthly Intravitreal Injections on Retinal Thickness Stability in Patients With Wet AMD »Details
  • Dose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular Degeneration »Details
  • Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis. »Details
  • A Multi-center Study to Assess the Efficacy and Safety of LX211 in Active Non-infectious Anterior Uveitis »Details
  • VEGF In Systemic Circulation Of ROP-infants »Details
  • A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis »Details
  • Study of Efficacy of Ranibizumab in Different Regimens in Patients With Diabetic Macula Edema »Details
  • Safety and Efficacy of Ranibizumab in Diabetic Macular Edema »Details
  • A Study of the Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema »Details
  • A Study of the Trabecular Micro-Bypass Stent in Combination With Cataract Surgery in Open Angle Glaucoma Subjects. »Details
  • Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO) »Details
  • Study Assessing Double-masked Uveitis Treatment »Details
  • Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis »Details
  • Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO) »Details
  • Bilateral Recession or Unilateral Recession-Resection as Surgery for Infantile Esotropia »Details
  • Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis »Details
  • Efficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia »Details
  • Prophylactic Intravitreal 5-Fluorouracil and Heparin to Prevent PVR in High-risk Patients With Retinal Detachment. »Details
  • Development of Novel Clinical Endpoints in Intermediate AMD »Details
  • A Study to Compare SB11 (Proposed Ranibizumab Biosimilar) to Lucentis in Subjects With Neovascular Age-related Macular Degeneration (AMD) »Details
  • A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration »Details
  • A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy »Details
  • Efficacy and Safety of Two Treatment Regimens of 0.5 mg Ranibizumab Intravitreal Injections Guided by Functional and/or Anatomical Criteria, in Patients With Neovascular Age-related Macular Degeneration »Details
  • ADenoVirus Initiative Study in Epidemiology in Germany »Details
  • Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO »Details
  • Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT) »Details
  • A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration »Details
  • Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES) »Details
  • Myfortic for the Treatment of Non-infectious Intermediate Uveitis »Details
  • A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema »Details
  • A Study of Safety, Tolerability, and Evidence of Activity of FCFD4514S Administered Monthly or Every Other Month to Patients With Geographic Atrophy »Details
  • An Extension Study to Evaluate the Long-Term Safety of Lampalizumab in Participants With Geographic Atrophy »Details
  • Compensation for Blindness With the Intelligent Retinal Implant System (IRIS V2) in Patients With Retinal Dystrophy »Details
  • Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS) »Details
  • Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity »Details
  • High Myopia: Extended and Longterm Observation of Pathologic Myopia Patients With the Risk for Developing a Myopic Choroidal Neovascularization (CNV) »Details
  • A Study to Assess the Efficacy and Safety of Abatacept in Adults With Active Primary Sjögrens Syndrome »Details
  • Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE) »Details
  • Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular Degeneration »Details
  • Evaluation of a Treat and Extend Regimen of Intravitreal Aflibercept for Macular Edema Secondary to CRVO »Details
  • A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema »Details
  • Safety and Efficacy Study of Topical Administration of FOV2304 (High Dose or Low Dose) for the Treatment of Center-involving Clinically Significant Macular Edema Associated With Diabetic Retinopathy »Details
  • A Study to Assess the Effects of Certolizumab Pegol on the Reduction of Anterior Uveitis (AU) Flares in Axial Spondyloarthritis Subjects With a Documented History of AU »Details
  • Study Evaluating Efficacy and Safety of PF-04523655 Versus Laser in Subjects With Diabetic Macular Edema »Details
Heidelberg
  • NovaTears® Eye Drops Observational Study »Details
  • A Study to Compare Ocular Safety and Tolerability of Prednisolone Acetate 0.5% Eye Drops Versus Vehicle in Healthy Volunteers »Details
  • Non-comparative Study to Assess the Visual Performances and Safety of a Progressive Multifocal Intraocular Lens »Details
  • Corneal Changes After Crosslinking in Keratoconus Patients Compared to the Untreated Fellow Eye »Details
  • Eye Movement Desensitization and Reprocessing (EMDR) in Non-specific Chronic Back Pain »Details
  • Management of Eyelid Disorders by Ophthalmologists in Usual Medical Practice »Details
  • Topical Omega-3 Fatty Acids (REMOGEN® OMEGA) in the Treatment of Dry Eye »Details
  • Local Tolerability and Safety of Povidone K25 Eye Drops (Artificial Tears Containing Povidone) Versus Placebo in Healthy Volunteers »Details
  • Comparison of WaveLight Analyzer and Alcon LadarWave »Details
  • Historical Case Record Survey of Visual Acuity Data From Patients With Leber's Hereditary Optic Neuropathy (LHON) »Details
  • NovaTears® Eye Drops Observational Study NT-002 »Details
  • A Prospective Evaluation of Glaucoma Subjects Treated With Two Second Generation iStents and One iStent Supra »Details
  • THE IPI - Trial in Advanced Melanoma: Melanoma Patients With Advanced Disease »Details
  • A Study for Management of Ocular Side Effects in Subjects With Glioblastoma Receiving Depatuxizumab Mafodotin »Details
  • A Single Centre Study to Analyze Cataract Surgery Following Femtosecond Laser-Assisted and Manual Cataract Surgery »Details
  • Adalimumab in Uveitis Refractory to Conventional Therapy (ADUR Trial) »Details
  • A Multi Focal Visual Outcome Study Using Different Near Additions »Details
  • Clinical Evaluation of the One-Piece Tecnis Multifocal Intraocular Lens (IOL) »Details
  • Long Term Observation of Patient Satisfaction Post INTRACOR Treatment Based on Patient Perception and Diagnostic Data »Details
  • Intrastromal Presbyopia Correction by Means of a Femtosecond Laser »Details
  • A Multi-Center Trial To Evaluate The Safety And Efficacy Of Pegaptanib Sodium(Macugen) Injected Into The Eye Every 6 Weeks For Up To 2 Years For Macular Swelling Associated With Diabetes, With An Open-Label Macugen Year Extension. »Details
  • STAR-LIFE Registry: STARflo Glaucoma Implant Clinical Experience Program »Details
  • STARflo European Safety and Efficacy Study »Details
  • Tepotinib Phase II in Non-small Cell Lung Cancer (NSCLC) Harboring MET Alterations »Details
  • INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD »Details
  • Safety and Efficacy of AIN457 in Noninfectious Uveitis »Details
  • ODM 5 in the Treatment of Corneal Edematous Fuchs' Endothelial Dystrophy »Details
  • Evaluation of the FluidVision Accommodating Lens »Details
  • Phase II HDM-SPIRE Safety and Efficacy Study »Details
  • Phase III Cat-PAD Study »Details
  • Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment »Details
  • Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis »Details
  • A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis »Details
  • Post-Market Clinical Investigation of the Clareon® IOL »Details
  • Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis »Details
  • Fundus Autofluorescence Imaging in Age-related Macular Degeneration Using Confocal Scanning Laser Ophthalmoscopy »Details
  • Social Interaction and Compassion in Depression »Details
  • 38 Week Extension Study to CAIN457C2303 »Details
  • Clinical Trial With PRECIZON Presbyopic »Details
  • A Double Blind Trial To Evaluate The Safety And Efficacy Of Eculizumab In Relapsing NMO Patients (PREVENT Study) »Details
  • An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients »Details
  • Efficacy and Safety of Intraseasonal Specific Immunotherapy With Depiquick® Birch »Details
  • Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma »Details
  • SUBLIVAC FIX Birch Phase III Short-term Efficacy »Details
  • A Study of the Intra-Patient Escalation Dosing Regimen With IMCgp100 in Patients With Advanced Uveal Melanoma »Details
  • Selumetinib (AZD6244: ARRY-142886) (Hyd-Sulfate) in Metastatic Uveal Melanoma (SUMIT) »Details
  • A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis »Details
  • SUBLIVAC FIX Phleum Pratense DT/DRF »Details
  • PURETHAL® Mites Dose Range Finding Study in Patients With Persistent Allergic Rhinitis/Rhinoconjunctivitis »Details
  • Phase III Study in Refractory Behcet's Disease »Details
  • Efficacy of Co-administration of Bilastine and Montelukast in Patients With SARC and Asthma »Details
Heilbronn
  • Safety and Performance Study of the ARGOS-IO (Intraocular) System in Patients With Primary Open Angle Glaucoma (POAG) »Details
Karlsruhe
  • Argus II Retinal Prosthesis System - Better Vision RP Study »Details
  • Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) »Details
  • Ocular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration »Details
  • Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension »Details
  • Alprostadil in Maculopathy Study (AIMS) »Details
  • Safety and Efficacy of Switching From Aflibercept to Ranibizumab in Patients With nAMD »Details
  • A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Either Avastin® or Eylea® Compared to Avastin® or Eylea® Monotherapy »Details
  • Argus® II Retinal Prosthesis System Post-Market Surveillance Study »Details
  • Safety and Efficacy of Brimonidine Intravitreal Implant in Patients With Geographic Atrophy Due to Age-related Macular Degeneration (AMD) »Details
  • Randomized Study for Efficacy and Safety of Ranibizumab 0.5mg in Treat-extend and Monthly Regimens in Patients With nAMD »Details
  • A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion »Details
Mannheim
  • Hypnosis for Eye Surgery »Details
  • Intrastromal Correction of Ametropia by a Femtosecond Laser »Details
  • Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema »Details
Tübingen
  • Spectral Domain OCT Imaging in Patients With Optic Nerve Head Drusen (Tuebingen SD-OCT IN OPTIC NERVE HEAD DRUSEN STUDY) »Details
  • Assessment of Visual Field-related Endpoints in Patients With Non-arteritic Ischemic Optic Neuropathy »Details
  • Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet`s Disease (INCYTOB) »Details
  • Comparison of Non-mydriatic Camera Systems in a Female Health Hospital »Details
  • Observation of Treatment Patterns With Lucentis in Approved Indications »Details
  • Comparison of Visual Fields: Humphrey Field Analyzer (HFA) SITA Strategy, SCOPE (GATE Strategy) and Humphrey MATRIX Perimeter »Details
  • Safety and Efficacy of a Single Subretinal Injection of rAAV.hCNGA3 in Patients With CNGA3-linked Achromatopsia »Details
  • Eye Screening in German Secondary Diabetes Care Centers »Details
  • Safety and Efficacy of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension »Details
  • Functional Neuroimaging of Cortical Plasticity in the Human Visual System »Details
  • BIIB033 In Acute Optic Neuritis (AON) »Details
  • Assessment of Advanced Glaucomatous Visual Field Loss and Its Impact on Visual Exploration, Activities of Daily Living (ADL) and Quality of Life (QoL) »Details
  • Long-Term Assessment of Remyelinating Therapy »Details
  • Comparison of a Smartphone Based Self Refraction Tool With Conventional Refraction Error Estimation Methods »Details
  • Phase I Dose Escalation Study to Investigate the Safety of ISTH0036 in Subjects With Glaucoma Undergoing Trabeculectomy »Details
  • Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients »Details
  • Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration »Details
  • Prospective Trial to Compare the Clinical Efficiency of G-EYE™ HD Colonoscopy With Standard HD Colonoscopy »Details
  • Screening for Advanced Heart Failure Treatment (SEE-HF) »Details
  • Observational Study - ILM Peeling »Details
  • Assessment of Psychological Strain and Perioperative Fear in Intravitreal Injections »Details
  • Exploratory Study on Topical ESBA105 in Acute Anterior Uveitis »Details
  • Efficacy and Safety of Voclosporin to Treat Active Noninfectious Uveitis »Details
  • Long-term Safety and Performance of the ARGOS-IO Intraocular Pressure Sensor System in Subjects With Primary Open Angle Glaucoma (POAG) »Details
  • Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert »Details
  • Study to Compare Standard Perimetry With the New Scotoma-Oriented Perimetry (SCOPE) Using a New Fast German Adaptive Threshold Estimation (GATE) in Glaucoma Patients »Details
  • THOR - Tübingen Choroideremia Gene Therapy Trial »Details
  • Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis or Retinitis Pigmentosa (Extension of Study RET IRD 01) »Details
  • Clinical Characterization on PDE6A-related Retinitis Pigmentosa in Preparation to a Gene Therapy Trial »Details
  • Post-Marketing Surveillance of Patients Using the Subretinal Retina Implant Alpha »Details
  • Transcorneal Electrostimulation for Therapy of Retinitis Pigmentosa »Details
  • Efficacy Study for Treatment of Dementia in Progressive Supranuclear Palsy »Details
  • Retina Implant Pilot Trial to Evaluate Safety & Efficacy in Blind Patients Having Degenerated Photo-receptors »Details
  • Natural History Study in Inherited Retinal Disease Subjects Caused by Mutations in RPE65 or LRAT »Details
  • Assessment of Homonymous Visual Loss and Its Impact on Visual Exploration, Activities of Daily Living (ADL) and Quality of Life (QoL) »Details
  • Long-term Safety and Efficacy Follow-up of AAV2-REP1 for the Treatment of Choroideremia (SOLSTICE) »Details
  • A Safety Study of Intravitreal PP-001 in Patients With Chronic, Non-Infectious Uveitis »Details
  • Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis »Details
  • Efficacy and Safety of Filgotinib in Adults With Active Noninfectious Uveitis »Details
  • A 4 Week Study With BI 144807 in Patients >= 50 Years With Wet Age Related Macular Degeneration »Details
  • The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular Dystrophy »Details
  • Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1) »Details
  • Long-term Safety of Gevokizumab in the Treatment of Patients With Chronic Non-infectious Uveitis (EYEGUARD-X) »Details
  • An Exploratory Study to Evaluate the Safety of Brimonidine Intravitreal Implant in Patients With Retinitis Pigmentosa »Details
  • Research of Biomarkers in Parkinson Disease »Details
  • A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration »Details
  • A Natural History of the Progression of Stargardt Disease: Retrospective and Prospective Studies »Details
  • A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration »Details
  • Transcorneal Electrical Stimulation - Multicenter Safety Study »Details
  • Safety and Effect on Central Retinal Thickness of BI 1026706 in Patients With Diabetic Macular Edema »Details
  • Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy »Details
  • A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular Edema »Details
  • A Double-masked, Placebo-controlled Study With Open Label Period to Evaluate MEDI-551 in Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders »Details
  • Efficacy and Safety of AAV2-REP1 for the Treatment of Choroideremia »Details
  • Natural History of the Progression of Choroideremia Study »Details
  • Dendritic Cells Plus Autologous Tumor RNA in Uveal Melanoma »Details
  • Revacept in Symptomatic Carotid Stenosis (Revacept/CS/02) »Details
  • Safety and Efficacy Study of Subcutaneous Belimumab and Intravenous Rituximab Co-administration in Subjects With Primary Sjogren's Syndrome »Details
  • Rate of Progression in USH2A Related Retinal Degeneration »Details
  • Safety/Proof of Concept Study of Oral QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT) Mutations »Details
  • Safety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration »Details
  • Post Marketing Surveillance Study of Dysport »Details
Ulm
  • Study to Compare the Efficacy and Safety of Two Non-Preserved Artificial Tears for the Treatment of Dry Eye Signs and Symptoms »Details
  • CyclASol® Phase 1 Study »Details
  • Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension »Details
  • Effect of Ruboxistaurin on Clinically Significant Macular Edema »Details
  • Dose Finding Study With CYT003-QbG10 in Patients With House Dust Mite Allergy »Details
  • Study of BIIB092 in Participants With Progressive Supranuclear Palsy »Details
  • A Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of ABBV-8E12 in Subjects With Progressive Supranuclear Palsy (PSP). »Details
  • Long-term Efficacy and Safety Study With Oralgen Grass Pollen »Details
  • Efficacy and Safety of Grass Pollen Sublingual Immunotherapy »Details
  • Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy »Details
  • A Long-Term Safety Study of OZURDEX® in Clinical Practice »Details
  • Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting »Details
  • Dose Finding Study for Depigoid Birch: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma »Details
  • Twin SUBLIVAC® Grasses Clinical Efficacy Study »Details
  • Reduction in the Occurrence of Center-Involved Diabetic Macular Edema »Details
  • Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder »Details
  • Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy »Details